JP7359526B2 - Chemical liquid volatilizer - Google Patents
Chemical liquid volatilizer Download PDFInfo
- Publication number
- JP7359526B2 JP7359526B2 JP2016256266A JP2016256266A JP7359526B2 JP 7359526 B2 JP7359526 B2 JP 7359526B2 JP 2016256266 A JP2016256266 A JP 2016256266A JP 2016256266 A JP2016256266 A JP 2016256266A JP 7359526 B2 JP7359526 B2 JP 7359526B2
- Authority
- JP
- Japan
- Prior art keywords
- container
- opening
- chemical solution
- chemical
- volatilization body
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000126 substance Substances 0.000 title claims description 97
- 239000007788 liquid Substances 0.000 title description 23
- 239000000243 solution Substances 0.000 claims description 63
- 230000002093 peripheral effect Effects 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 5
- 239000006200 vaporizer Substances 0.000 claims description 5
- 239000008155 medical solution Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 description 9
- 238000010186 staining Methods 0.000 description 6
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 241000345998 Calamus manan Species 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 235000012950 rattan cane Nutrition 0.000 description 4
- -1 for example Substances 0.000 description 3
- 230000005484 gravity Effects 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 239000002781 deodorant agent Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000000077 insect repellent Substances 0.000 description 2
- 229930182556 Polyacetal Natural products 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
Description
本発明は、薬液揮散器に関する。 The present invention relates to a chemical vaporizer.
従来より、薬液が収容された容器内に、棒状の揮散体を容器内から突出するような態様で挿入して使用する薬液揮散器が知られている(例えば、特許文献1参照)。この種の薬液揮散器では、容器内の薬液が揮散体に吸い上げられて外部空間に揮散することで、薬液の有する芳香効果等の効果が外部空間に付与される。 BACKGROUND ART Conventionally, there has been known a chemical liquid volatilizer that is used by inserting a rod-shaped volatilization body into a container containing a chemical liquid in such a manner that it protrudes from inside the container (see, for example, Patent Document 1). In this type of chemical volatilizer, the chemical liquid in the container is sucked up by the volatilization body and volatilized into the external space, thereby imparting the aromatic effect and other effects of the chemical liquid to the external space.
薬液を吸い上げる揮散体としては、様々なタイプのものがあるが、一例を挙げると、ラタン製のものが広く用いられている。ラタン製の揮散体は、内部の微細孔を介して毛細管現象により薬液を吸い上げ、このとき、薬液が内部の微細孔から外表面に染み出す。揮散体は、薬液を吸い上げて外部空間へ揮散させる役割を担うため、多くの場合、使用中、その外表面には薬液が付着する。なお、このことは、ラタン製の揮散体に限られない。 There are various types of volatilizers that suck up chemical solutions, but one example is one made of rattan that is widely used. The rattan volatilization body sucks up the chemical solution through the internal micropores by capillary action, and at this time, the chemical solution seeps out from the internal micropores to the outer surface. Since the volatilization body plays the role of sucking up the chemical liquid and volatilizing it into the external space, the chemical liquid often adheres to its outer surface during use. Note that this is not limited to rattan volatile bodies.
図1は、特許文献1に記載の薬液揮散器の容器の上部の開口付近を拡大した側方断面図である。同図に示すとおり、容器内に挿入された揮散体は、容器の開口を囲む周縁部と接触する。そのため、揮散体の外表面に付着した薬液は、しばしばこの揮散体と周縁部との接点付近に溜まり、その後、容器の外壁面を伝って流れ落ちることがある。その場合、容器に触れた人の手や壁や家財等が薬液で汚されてしまうことになりかねない。 FIG. 1 is an enlarged side sectional view of the vicinity of the opening at the top of the container of the chemical solution volatilizer described in Patent Document 1. As shown in the figure, the volatile material inserted into the container comes into contact with the peripheral edge surrounding the opening of the container. Therefore, the chemical liquid adhering to the outer surface of the volatilized body often accumulates near the contact point between the volatilized body and the peripheral edge, and then flows down along the outer wall surface of the container. In that case, the hands, walls, household goods, etc. of those who touched the container may become contaminated with the chemical solution.
本発明は、揮散体に吸い上げられた薬液が容器の外壁面を汚すことを防止することができる薬液揮散器を提供することを目的とする。 An object of the present invention is to provide a chemical solution volatilizer that can prevent the chemical solution sucked up by the volatilization body from staining the outer wall surface of a container.
本発明の第1観点に係る薬液揮散器は、上部に開口を有する容器と、前記容器内に収容される薬液と、棒状の揮散体とを備える。前記揮散体は、前記薬液を前記容器内から吸い上げ、外部空間に揮散させるべく、前記容器外へ一部が露出するように前記開口を介して前記容器内に挿入される。前記容器は、前記開口を囲んで前記開口を画定する周縁部を含む。前記周縁部は、前記開口に面する第1内面と、前記開口に面する第2内面とを有する。前記第2内面は、前記第1内面よりも前記開口の径方向内側に位置するとともに、前記第1内面よりも下方に位置する。前記第1内面と前記第2内面とは、滑らかに連続しておらず、前記容器内に挿入された前記揮散体は、前記第1内面と距離を保ちつつ、前記第2内面と接触する。 A chemical solution volatilizer according to a first aspect of the present invention includes a container having an opening at the top, a chemical solution accommodated in the container, and a rod-shaped volatilization body. The volatilization body is inserted into the container through the opening so that a portion of the volatilization body is exposed to the outside of the container in order to suck up the chemical solution from inside the container and volatilize it into an external space. The container includes a periphery surrounding and defining the opening. The peripheral portion has a first inner surface facing the opening and a second inner surface facing the opening. The second inner surface is located radially inside the opening than the first inner surface, and is located below the first inner surface. The first inner surface and the second inner surface are not smoothly continuous, and the volatile body inserted into the container contacts the second inner surface while maintaining a distance from the first inner surface.
本発明の第2観点に係る薬液揮散器は、第1観点に係る薬液揮散器であって、前記揮散体が前記容器内において上下方向に対し最も傾斜しているとき、前記揮散体が前記第2内面と接触し、前記揮散体に対し前記開口の径方向外側に前記第1内面が位置する。 A chemical solution volatilizer according to a second aspect of the present invention is the chemical solution volatilizer according to the first aspect, in which when the volatilization body is most inclined with respect to the vertical direction in the container, the volatilization body The first inner surface is in contact with the second inner surface and is located on the radially outer side of the opening with respect to the volatilization body.
本発明の第3観点に係る薬液揮散器は、第1観点又は第2観点に係る薬液揮散器であって、前記第1内面は、上に向かう程、前記開口の径方向外側に向かうように傾斜する傾斜面を形成している。 A chemical solution volatilizer according to a third aspect of the present invention is the chemical solution volatilizer according to the first or second aspect, in which the first inner surface is arranged such that as it goes upward, it goes toward the outside in the radial direction of the opening. It forms an inclined surface.
本発明の第4観点に係る薬液揮散器は、第3観点に係る薬液揮散器であって、前記第1内面と前記第2内面とは、連続している。 The chemical volatilizer according to the fourth aspect of the present invention is the chemical volatilizer according to the third aspect, in which the first inner surface and the second inner surface are continuous.
本発明の第5観点に係る薬液揮散器は、第1観点から第3観点のいずれかに係る薬液揮散器であって、前記第1内面と前記第2内面とは、段差を形成している。 A chemical volatilizer according to a fifth aspect of the present invention is a chemical volatilizer according to any one of the first to third aspects, wherein the first inner surface and the second inner surface form a step. .
本発明の第6観点に係る薬液揮散器は、第1観点から第5観点のいずれかに係る薬液揮散器であって、前記第1内面の上端と前記第2内面の上端との間の上下方向の長さは、0.5mm以上である。 A chemical solution volatilizer according to a sixth aspect of the present invention is a chemical solution volatilizer according to any one of the first to fifth aspects, in which the upper and lower portions between the upper end of the first inner surface and the upper end of the second inner surface are The length in the direction is 0.5 mm or more.
本発明によれば、容器の上部の開口を画定する周縁部に、共に開口に面する第1内面及び第2内面が形成されている。第2内面は、第1内面よりも内側かつ下方に位置する。そして、容器内に挿入された揮散体は、第2内面に接触するが、この第2内面が障壁となって、第1内面と距離を保つ。その結果、揮散体と第1内面との間に空間が形成され、揮散体の外表面に付着した薬液は、容器の外壁面に達することができない。これにより、揮散体に吸い上げられた薬液が容器の外壁面を汚すことを防止することができる。 According to the present invention, the first inner surface and the second inner surface, both facing the opening, are formed at the peripheral edge defining the opening at the top of the container. The second inner surface is located inside and below the first inner surface. The volatilization body inserted into the container comes into contact with the second inner surface, but this second inner surface acts as a barrier and maintains a distance from the first inner surface. As a result, a space is formed between the volatilization body and the first inner surface, and the chemical liquid adhering to the outer surface of the volatilization body cannot reach the outer wall surface of the container. Thereby, it is possible to prevent the chemical liquid sucked up by the volatile body from staining the outer wall surface of the container.
以下、図面を参照しつつ、本発明の幾つかの実施形態に係る薬液揮散器について説明する。 DESCRIPTION OF EMBODIMENTS Hereinafter, chemical solution volatilizers according to some embodiments of the present invention will be described with reference to the drawings.
<1.第1実施形態>
<1-1.薬液揮散器の全体構成>
図2に、第1実施形態に係る薬液揮散器1の外観図を示す。同図に示すように、薬液揮散器1は、薬液が収容される容器2と、容器2内に挿入される複数本の棒状の揮散体3とを備える。容器2は、上部に開口S1を有し、この開口S1を介して薬液を内部空間S2内に収容することができる。なお、本明細書でいう「上」「下」は、特に断らない限り、図2に示す使用状態を基準に定義される。
<1. First embodiment>
<1-1. Overall configuration of chemical vaporizer>
FIG. 2 shows an external view of the chemical vaporizer 1 according to the first embodiment. As shown in the figure, the chemical solution volatilization device 1 includes a container 2 in which a chemical solution is stored, and a plurality of rod-shaped volatilization bodies 3 inserted into the container 2. The container 2 has an opening S1 at the top, and can accommodate the chemical liquid into the internal space S2 through the opening S1. Note that "upper" and "lower" in this specification are defined based on the usage state shown in FIG. 2, unless otherwise specified.
棒状の揮散体3は、容器2内から突出するような態様で容器2内に挿入される。すなわち、揮散体3は、容器2の高さに対し十分な長さを有しており、下端部3aが容器2内に配置され、上端部3bが容器2外に露出するような態様で、開口S1を介して容器2の内部空間S2内に挿入される。また、揮散体3は、後述されるように、薬液を毛細管現象により重力に逆らって吸い上げることが可能な構造を有している。その結果、容器2内の薬液は、揮散体3を伝って下端部3aから上端部3bまで上昇することができ、揮散体3の外表面から外部空間へと揮散(自然蒸散)する。これにより、薬液は、薬液揮散器1の置かれた周囲の空間へ拡散される。 The rod-shaped volatilization body 3 is inserted into the container 2 in such a manner that it protrudes from inside the container 2 . That is, the volatilization body 3 has a sufficient length relative to the height of the container 2, and is arranged in such a manner that the lower end 3a is disposed inside the container 2 and the upper end 3b is exposed outside the container 2. It is inserted into the internal space S2 of the container 2 through the opening S1. Further, as will be described later, the volatilization body 3 has a structure capable of sucking up the chemical liquid against gravity by capillary action. As a result, the chemical solution in the container 2 can rise along the volatilization body 3 from the lower end 3a to the upper end 3b, and volatilize (natural evaporation) from the outer surface of the volatilization body 3 into the external space. Thereby, the chemical liquid is diffused into the space around the chemical liquid volatilizer 1.
ここで使用される薬液は、特にその種類は限定されないが、典型的には芳香剤、消臭剤又は防虫剤、或いはこれらの混合物であり、使用目的に応じて、香料、消臭成分、防虫成分、着色料等の添加剤が含有される。薬液に含まれる溶媒は、使用される添加剤の種類に応じて適宜選択され、親水性溶媒又は親油性溶媒、或いはこれらの混合物とすることができる。薬液が香料を含む場合には、その香り強度を高めるために、溶媒として少なくとも親油性溶媒を含むことが好ましい。親水性溶媒としては、例えば、水又はエタノール、或いはこれらの混合物を使用することができる。親油性溶媒としては、例えば、グリコールエーテル又はイソパラフィン系溶媒、或いはこれらの混合物を使用することができる。また、薬液には、香料、消臭成分、防虫成分、着色料等の機能性成分を可溶化させるために、溶解剤が含まれていてもよい。 The chemical solution used here is not particularly limited in type, but typically is a fragrance, a deodorant, an insect repellent, or a mixture thereof. Contains additives such as ingredients and colorants. The solvent contained in the drug solution is appropriately selected depending on the type of additive used, and can be a hydrophilic solvent, a lipophilic solvent, or a mixture thereof. When the medicinal solution contains a fragrance, it is preferable to contain at least a lipophilic solvent as a solvent in order to increase the fragrance intensity. As the hydrophilic solvent, for example, water or ethanol, or a mixture thereof can be used. As the lipophilic solvent, for example, glycol ether or isoparaffinic solvent, or a mixture thereof can be used. Further, the chemical solution may contain a solubilizing agent in order to solubilize functional components such as fragrances, deodorant components, insect repellent components, and colorants.
揮散体3の形状及び材質は、薬液を吸い上げて外部に揮散させることができる限り、特に限定されない。揮散体3は、典型的には、内部に微細孔を有する細長い略円柱形状を有しており、ラタン等の天然素材から構成することもできるし、ポリエチレン、ポリアセタール等の合成樹脂から構成することもできる。本実施形態に係る揮散体3は、図5に示す横断面形状を有する。この例では、揮散体3は、ポリエチレンテレフタレートとポリウレタンから構成され、内部に多数の不定形の微細孔31を有する。また、この揮散体3は、外表面が凹凸形状を有しており、外表面には、多数の溝32が形成されている。これらの溝32は、揮散体3の軸方向に沿って下端部3aから上端部3bまで筋状に延びている。また、これらの溝32は、揮散体3の周方向に沿って概ね等間隔に配置されている。従って、薬液は毛細管現象により、微細孔31だけでなく、溝32に沿っても吸い上げられる。そのため、本実施形態の揮散体3の外表面には、薬液が多量に付着し易くなっている。 The shape and material of the volatilization body 3 are not particularly limited as long as the chemical liquid can be sucked up and volatilized to the outside. The volatile body 3 typically has an elongated, substantially cylindrical shape with micropores inside, and can be made of natural materials such as rattan, or synthetic resins such as polyethylene and polyacetal. You can also do it. The volatilization body 3 according to this embodiment has a cross-sectional shape shown in FIG. In this example, the volatile body 3 is made of polyethylene terephthalate and polyurethane, and has a large number of irregularly shaped micropores 31 inside. Further, this volatilization body 3 has an uneven outer surface, and a large number of grooves 32 are formed on the outer surface. These grooves 32 extend linearly along the axial direction of the volatilization body 3 from the lower end 3a to the upper end 3b. Further, these grooves 32 are arranged at approximately equal intervals along the circumferential direction of the volatilization body 3. Therefore, the chemical solution is sucked up not only through the micropores 31 but also along the grooves 32 due to capillary action. Therefore, a large amount of chemical liquid tends to adhere to the outer surface of the volatile body 3 of this embodiment.
<1-2.容器の詳細>
容器2は、内部空間S2を画定する底部10及び周壁部20を有する。本実施形態では、底部10は、中央部11がその外周部12よりもやや上方に隆起した形状を有している。従って、容器2内の薬液は、残量が少なくなると、底部10の周縁に溜まることになる。一方で、棒状の揮散体3の下端部3aは、通常、底部10の傾斜に沿って下降し、底部10の周縁に配置される。従って、揮散体3と薬液とが接触し易い構成となっているため、薬液を最後まで使い切ることができる。
<1-2. Container details>
The container 2 has a bottom portion 10 and a peripheral wall portion 20 that define an interior space S2. In the present embodiment, the bottom portion 10 has a shape in which a central portion 11 is slightly raised upwardly than an outer circumferential portion 12 thereof. Therefore, when the remaining amount of the chemical solution in the container 2 decreases, it accumulates around the periphery of the bottom portion 10. On the other hand, the lower end 3 a of the rod-shaped volatilization body 3 usually descends along the slope of the bottom 10 and is disposed at the periphery of the bottom 10 . Therefore, since the volatile body 3 and the chemical solution are configured to easily come into contact with each other, the chemical solution can be used up to the end.
周壁部20は、筒状の胴部21と、胴部21の上端に連続する肩部22と、さらに肩部22の上端に連続する首部23(周縁部)とを有している。首部23は、容器2の上部の開口S1を囲む筒状の部位であり、胴部21よりも幅狭である。これにより、薬液揮散器1の転倒時には肩部22が壁となり、薬液が開口S1を介してこぼれにくくなっている。特に本実施形態では、首部23が胴部21と同軸に配置されているため、薬液揮散器1がどの方向に転倒したとしても肩部22が壁となり、薬液のこぼれを抑制することができる。また、開口S1の横断面の面積が胴部21の横断面の面積(内部空間S2の横断面の面積)よりも狭いため、容器2内に収容される薬液の量に対し、開口S1を介して容器2内から自然蒸散する薬液の量を抑制することができる。 The peripheral wall portion 20 has a cylindrical body portion 21, a shoulder portion 22 continuous to the upper end of the body portion 21, and a neck portion 23 (peripheral portion) continuous to the upper end of the shoulder portion 22. The neck portion 23 is a cylindrical portion surrounding the opening S1 at the top of the container 2, and is narrower than the body portion 21. Thereby, when the chemical solution volatilizer 1 falls, the shoulder portion 22 becomes a wall, making it difficult for the chemical solution to spill through the opening S1. In particular, in this embodiment, since the neck part 23 is arranged coaxially with the body part 21, the shoulder part 22 becomes a wall even if the chemical solution volatilizer 1 falls in any direction, and spilling of the chemical solution can be suppressed. In addition, since the area of the cross section of the opening S1 is smaller than the area of the cross section of the body 21 (the area of the cross section of the internal space S2), the amount of medicinal solution stored in the container 2 is reduced through the opening S1. Therefore, the amount of the chemical solution that evaporates naturally from inside the container 2 can be suppressed.
上記のとおり、開口S1を画定する首部23内には、複数本の揮散体3が差し込まれる。このとき、揮散体3により開口S1全体が塞がれてしまわない程度の余裕を持って、揮散体3を開口S1内に挿入することが好ましい。この場合、揮散体3を容器2内で傾斜させて配置することができ、美観を向上させることができるからである。また、美観をさらに向上させる観点からは、図2に示すように、複数本の揮散体3を様々な方向に放射状に延びるように配置することがより好ましい。 As described above, a plurality of volatilization bodies 3 are inserted into the neck portion 23 that defines the opening S1. At this time, it is preferable to insert the volatilization body 3 into the opening S1 with enough margin to prevent the volatilization body 3 from blocking the entire opening S1. In this case, the volatilization body 3 can be arranged at an angle within the container 2, and the aesthetic appearance can be improved. Moreover, from the viewpoint of further improving the aesthetic appearance, it is more preferable to arrange a plurality of volatilization bodies 3 so as to extend radially in various directions, as shown in FIG.
容器2の材質は特に限定されないが、例えば、ガラス製やプラスチック製とすることができる。薬液の残量を外部から視認できるようにする観点からは、容器2は、透明(半透明を含む)に形成されていることが好ましい。 The material of the container 2 is not particularly limited, but may be made of glass or plastic, for example. From the viewpoint of making the remaining amount of the chemical liquid visible from the outside, it is preferable that the container 2 is formed to be transparent (including translucent).
図3は、容器2の平面図であり、図4は、薬液揮散器1の容器2の首部23付近を拡大した側方断面図である。これらの図に示されるように、本実施形態では、首部23の上部が径方向内側において傾斜面を形成している。この傾斜面は、図4の例では側面視において直線状であるが、側面視において湾曲していてもよい。なお、本明細書における径方向とは、特に断らない限り、開口S1の中心軸を基準として定義される。また、本実施形態では、開口S1、内部空間S2、首部23、肩部22及び胴部21の中心軸は、同軸である。 3 is a plan view of the container 2, and FIG. 4 is an enlarged side sectional view of the vicinity of the neck portion 23 of the container 2 of the chemical solution volatilizer 1. As shown in these figures, in this embodiment, the upper part of the neck portion 23 forms an inclined surface on the radially inner side. Although this inclined surface is linear in side view in the example of FIG. 4, it may be curved in side view. Note that the radial direction in this specification is defined with the central axis of the opening S1 as a reference unless otherwise specified. Further, in this embodiment, the central axes of the opening S1, the internal space S2, the neck portion 23, the shoulder portion 22, and the body portion 21 are coaxial.
首部23は、共に開口S1に面する第1内面41及び第2内面42を有しており、第1内面41と第2内面42とは、互いに連続している。ただし、第1内面41と第2内面42とは、お互いの境界となる点P2において滑らかに連続していない。言い換えると、第1内面41及び第2内面42は、各々滑らかな連続面を形成しているが、お互いの境界となる点P2において折れ曲がっている。なお、P1は、第1内面41の上端の点を表し、P2は、第2内面42の上端の点を表すものとする。本実施形態では、点P2は、第1内面41の下端の点に連続している。 The neck portion 23 has a first inner surface 41 and a second inner surface 42 that both face the opening S1, and the first inner surface 41 and the second inner surface 42 are continuous with each other. However, the first inner surface 41 and the second inner surface 42 are not smoothly continuous at a point P2 that serves as a boundary between them. In other words, the first inner surface 41 and the second inner surface 42 each form a smooth continuous surface, but are bent at a point P2 that forms a boundary between them. Note that P1 represents a point at the upper end of the first inner surface 41, and P2 represents a point at the upper end of the second inner surface 42. In this embodiment, the point P2 is continuous with the lower end point of the first inner surface 41.
第2内面42は、第1内面41よりも径方向内側に位置しており、さらに第1内面41よりも下方に位置している。本実施形態では、第1内面41は、上に向かう程、径方向外側に向かうように傾斜する傾斜面を形成している。第2内面42は、上下方向に略平行に延びている。 The second inner surface 42 is located radially inward than the first inner surface 41 and further below the first inner surface 41. In this embodiment, the first inner surface 41 forms an inclined surface that is inclined radially outward as it goes upward. The second inner surface 42 extends substantially parallel to the vertical direction.
図4は、容器2内に挿入された揮散体3が上下方向に対して最も傾斜した状態(以下、最傾状態という)を示している。最傾状態では、揮散体3は、下端部3aが底部10の外周部12に接触するとともに、第2内面42の上端の点P2に接触する。このとき、揮散体3は、第1内面41と距離を保ちつつ、第2内面42の上端の点P2に接触する。つまり、最傾状態では、第2内面42が第1内面41と揮散体3とを離間させるため、揮散体3は第1内面41には接触せず、揮散体3と第1内面41との間には空間S3が形成される。従って、最傾状態の第1内面41は、揮散体3に対して径方向外側に配置される。 FIG. 4 shows a state in which the volatilization body 3 inserted into the container 2 is most inclined with respect to the vertical direction (hereinafter referred to as the most inclined state). In the most tilted state, the lower end 3a of the volatilization body 3 contacts the outer peripheral portion 12 of the bottom portion 10 and also contacts the point P2 at the upper end of the second inner surface 42. At this time, the volatilization body 3 contacts the point P2 at the upper end of the second inner surface 42 while maintaining a distance from the first inner surface 41. That is, in the most inclined state, the second inner surface 42 separates the first inner surface 41 and the volatilization body 3, so the volatilization body 3 does not contact the first inner surface 41, and the volatilization body 3 and the first inner surface 41 are separated from each other. A space S3 is formed between them. Therefore, the first inner surface 41 in the most inclined state is arranged radially outward with respect to the volatilization body 3.
揮散体3の軸方向が上下方向と為す角度をθ1とする。また、側面視において第1内面41と上下方向との為す角をθ2とする。このとき、最傾状態においても、θ2>θ1となる。 The angle between the axial direction of the volatile body 3 and the vertical direction is defined as θ1. Further, in a side view, the angle formed by the first inner surface 41 and the vertical direction is θ2. At this time, even in the most inclined state, θ2>θ1.
また、首部23は、第1内面41の上端の点P1に連続する上面44を有しており、さらに上面44の径方向の最外点P4から連続する外壁面45を有している。上面44及び外壁面45は、共に容器2の外部空間に面している。上面44は、水平方向に平行であり、外壁面45は、容器2の側方の外部空間に面している。本実施形態に係る外壁面45の上部は、図4に示すとおり、側面視において径方向外側に凸形状の丸味を帯びている。なお、上面44は、水平面に対して傾斜していてもよい。また、上面44は、省略可能である。 Further, the neck portion 23 has an upper surface 44 that is continuous to the point P1 at the upper end of the first inner surface 41, and further has an outer wall surface 45 that is continuous from the outermost point P4 of the upper surface 44 in the radial direction. The upper surface 44 and the outer wall surface 45 both face the external space of the container 2. The upper surface 44 is parallel to the horizontal direction, and the outer wall surface 45 faces the external space on the side of the container 2. As shown in FIG. 4, the upper part of the outer wall surface 45 according to this embodiment has a rounded shape that is convex outward in the radial direction when viewed from the side. Note that the upper surface 44 may be inclined with respect to the horizontal plane. Further, the upper surface 44 can be omitted.
以上の構成より、揮散体3の外表面に付着した薬液は、当該外表面に沿って滴り落ち、しばしば揮散体3と首部23との接点、本実施形態では、揮散体3と第2内面42との接点となる点P2付近に溜まることがある。しかしながら、この薬液が容器2の外壁面45に達することはない。すなわち、第1内面41が上下方向に延びているため、これが空間S3の外壁となって、空間S3が「薬液のプール」となる。そのため、薬液が、第1内面41及び上面44を超えて外壁面45に達することがない。その結果、容器2の外壁面45に沿って薬液が滴り落ち、薬液で外壁面45が汚れてしまうことが防止される。ひいては、容器2の外壁面45に触れる人の手や壁や家財等が薬液で汚れることもない。また、本実施形態では、空間S3の底面ともなる第1内面41が径方向内側に向かう程、下に向かうように傾斜しているため、空間S3内に漏れ出た薬液は重力により、第1内面41に沿って容器2の内部空間S2内に戻される。そのため、益々、薬液が外壁面45を汚す虞が低減される。 With the above configuration, the chemical liquid adhering to the outer surface of the volatilization body 3 drips down along the outer surface, often at the contact point between the volatilization body 3 and the neck 23, or in this embodiment, at the point of contact between the volatilization body 3 and the second inner surface 42. may accumulate near point P2, which is the point of contact with. However, this chemical solution never reaches the outer wall surface 45 of the container 2. That is, since the first inner surface 41 extends in the vertical direction, it becomes an outer wall of the space S3, and the space S3 becomes a "pool of chemical solution." Therefore, the chemical solution does not reach the outer wall surface 45 beyond the first inner surface 41 and the upper surface 44. As a result, the chemical liquid is prevented from dripping along the outer wall surface 45 of the container 2, and the outer wall surface 45 is prevented from becoming contaminated with the chemical liquid. Furthermore, the hands of the person who touches the outer wall surface 45 of the container 2, the walls, household goods, etc., will not be soiled with the chemical solution. Further, in this embodiment, since the first inner surface 41, which also serves as the bottom surface of the space S3, is inclined downward as it goes radially inward, the chemical solution leaking into the space S3 is caused by gravity to the first inner surface 41. It is returned into the internal space S2 of the container 2 along the inner surface 41. Therefore, the risk of the chemical liquid staining the outer wall surface 45 is further reduced.
以上のとおり、薬液が外壁面45を汚さないようにする観点からは、第1内面41の上端の点P1と第2内面42の上端の点P2との間の上下方向の長さw1は、0.5mm≦w1であることが好ましく、1.0mm≦w1であることがより好ましく、2.0mm≦w1であることがさらに好ましい。また、w1≦30mmであることが好ましく、w1≦20mmであることがより好ましく、w1≦10mmであることがさらに好ましい。また、同様の観点から、第1内面41の上端の点P1と第2内面42の上端の点P2との間の水平方向の長さw2は、1.0mm≦w2であることが好ましく、2.0mm≦w2であることがより好ましく、3.0mm≦w2であることがさらに好ましい。また、w2≦45mmであることが好ましく、w2≦30mmであることがより好ましく、w2≦15mmであることがさらに好ましい。 As described above, from the viewpoint of preventing the chemical solution from staining the outer wall surface 45, the length w1 in the vertical direction between the point P1 at the upper end of the first inner surface 41 and the point P2 at the upper end of the second inner surface 42 is It is preferable that 0.5 mm≦w1, more preferably 1.0 mm≦w1, and even more preferably 2.0 mm≦w1. Moreover, it is preferable that w1≦30 mm, more preferably that w1≦20 mm, and even more preferably that w1≦10 mm. Further, from the same viewpoint, the horizontal length w2 between the upper end point P1 of the first inner surface 41 and the upper end point P2 of the second inner surface 42 is preferably 1.0 mm≦w2; It is more preferable that .0 mm≦w2, and even more preferable that 3.0 mm≦w2. Moreover, it is preferable that w2≦45 mm, more preferably that w2≦30 mm, and even more preferably that w2≦15 mm.
また、揮散体3の水平面に対する角度が大きい程、薬液が揮散体3から空間S3内へ滴り落ちにくくなる。従って、最傾状態での揮散体3の水平面に対する角度θ3(=90°-θ1)は、45°≦θ3であることが好ましく、60°≦θ3であることがより好ましい。 Moreover, the greater the angle of the volatilization body 3 with respect to the horizontal plane, the more difficult it becomes for the chemical solution to drip from the volatilization body 3 into the space S3. Therefore, the angle θ3 (=90°−θ1) of the volatile body 3 with respect to the horizontal plane in the most inclined state is preferably 45°≦θ3, and more preferably 60°≦θ3.
<2.第2実施形態>
次に、図6及び図7を参照しつつ、第2実施形態に係る薬液揮散器について説明する。なお、第1実施形態と第2実施形態とは、容器の構造が異なるものの、両者は多くの点で共通する。従って、以下では、主として両者の相違点について説明し、共通の要素には同じ参照符号を付して説明を省略する。
<2. Second embodiment>
Next, a chemical solution volatilizer according to a second embodiment will be described with reference to FIGS. 6 and 7. Note that although the first embodiment and the second embodiment differ in the structure of the container, they have many points in common. Therefore, below, the differences between the two will be mainly explained, and common elements will be given the same reference numerals and explanations will be omitted.
図6は、本実施形態に係る容器102の平面図であり、図7は、容器102の首部23付近を拡大した側方断面図である。これらの図に示されるように、本実施形態では、首部23の上部が径方向内側において段差D1を形成している。 FIG. 6 is a plan view of the container 102 according to this embodiment, and FIG. 7 is an enlarged side sectional view of the vicinity of the neck 23 of the container 102. As shown in these figures, in this embodiment, the upper part of the neck portion 23 forms a step D1 on the radially inner side.
首部23は、共に開口S1に面する第1内面41及び第2内面42を有しており、さらにこれらの内面41,42の間に同じく開口S1に面する第3内面43を有している。第1内面41、第3内面43及び第2内面42は、この順番に互いに連続しているが、お互いの境界となる点P3,P2において滑らかに連続していない。言い換えると、第1内面41、第3内面43及び第2内面42は、各々滑らかな連続面を形成しているが、お互いの境界となる点P3,P2において折れ曲がっている。なお、P3とは、第3内面43の上端の点を表すものとする。本実施形態では、点P3は、第1内面41の下端の点に連続しており、点P2は、第3内面43の下端の点に連続している。 The neck portion 23 has a first inner surface 41 and a second inner surface 42 that both face the opening S1, and further has a third inner surface 43 that also faces the opening S1 between these inner surfaces 41 and 42. . Although the first inner surface 41, the third inner surface 43, and the second inner surface 42 are continuous with each other in this order, they are not smoothly continuous at points P3 and P2, which are the boundaries between them. In other words, the first inner surface 41, the third inner surface 43, and the second inner surface 42 each form a smooth continuous surface, but are bent at points P3 and P2 that serve as mutual boundaries. Note that P3 represents a point at the upper end of the third inner surface 43. In this embodiment, the point P3 is continuous with the lower end point of the first inner surface 41, and the point P2 is continuous with the lower end point of the third inner surface 43.
第2内面42は、第1内面41よりも径方向内側に位置しており、さらに第1内面41よりも下方に位置している。本実施形態では、第1内面41及び第3内面43は、上に向かう程、径方向外側に向かうように傾斜する傾斜面を形成しており、第1内面41が構成する傾斜面の方が、第3内面43が構成する傾斜面よりも上下方向に対し急峻に傾斜している。第2内面42は、上下方向に略平行に延びている。第1内面41と第2内面42とは、第3内面43を介して段差D1を形成している。なお、第1内面41及び第3内面43が形成する傾斜面は、図7の例では側面視において直線状であるが、側面視において湾曲していてもよい。 The second inner surface 42 is located radially inward than the first inner surface 41 and further below the first inner surface 41. In this embodiment, the first inner surface 41 and the third inner surface 43 form an inclined surface that is inclined radially outward as it goes upward, and the inclined surface formed by the first inner surface 41 is , is more steeply inclined in the vertical direction than the inclined surface constituted by the third inner surface 43. The second inner surface 42 extends substantially parallel to the vertical direction. The first inner surface 41 and the second inner surface 42 form a step D1 with the third inner surface 43 in between. In addition, although the inclined surface formed by the first inner surface 41 and the third inner surface 43 is straight in a side view in the example of FIG. 7, it may be curved in a side view.
図7は、容器102内に挿入された揮散体3が上下方向に対して最も傾斜した状態(以下、最傾状態という)を示している。最傾状態では、揮散体3は、下端部3aが底部10の外周部12に接触するとともに、第2内面42の上端の点P2に接触する。このとき、揮散体3は、第1内面41と距離を保ちつつ、第2内面42の上端の点P2に接触する。つまり、最傾状態では、第2内面42が第1内面41と揮散体3とを離間させるため、揮散体3は第1内面41には接触せず、揮散体3と第1内面41との間には空間S3が形成される。従って、最傾状態の第1内面41は、揮散体3に対して径方向外側に配置される。 FIG. 7 shows a state in which the volatilization body 3 inserted into the container 102 is most inclined with respect to the vertical direction (hereinafter referred to as the most inclined state). In the most tilted state, the lower end 3a of the volatilization body 3 contacts the outer peripheral portion 12 of the bottom portion 10 and also contacts the point P2 at the upper end of the second inner surface 42. At this time, the volatilization body 3 contacts the point P2 at the upper end of the second inner surface 42 while maintaining a distance from the first inner surface 41. That is, in the most inclined state, the second inner surface 42 separates the first inner surface 41 and the volatilization body 3, so the volatilization body 3 does not contact the first inner surface 41, and the volatilization body 3 and the first inner surface 41 are separated from each other. A space S3 is formed between them. Therefore, the first inner surface 41 in the most inclined state is arranged radially outward with respect to the volatilization body 3.
揮散体3の軸方向が上下方向と為す角度をθ1とし、(開口S1の周方向に同じ位置にある)点P1と点P2とを結ぶ直線と上下方向との為す角をθ2とする。このとき、最傾状態においても、θ2>θ1となる。 Let θ1 be the angle that the axial direction of the volatile body 3 makes with the vertical direction, and let θ2 be the angle that the vertical direction makes with the straight line connecting points P1 and P2 (located at the same position in the circumferential direction of the opening S1). At this time, even in the most inclined state, θ2>θ1.
また、首部23は、第1内面41の上端の点P1に連続する上面44を有しており、さらに上面44の径方向の最外点P4から連続する外壁面45を有している。上面44及び外壁面45は、共に容器102の外部空間に面している。上面44は、水平方向に平行であり、外壁面45は、容器102の側方の外部空間に面している。本実施形態に係る外壁面45の上部は、図7に示すとおり、側面視において径方向外側に凸形状の丸味を帯びている。なお、上面44は、水平面に対して傾斜していてもよい。また、上面44は、省略可能である。 Further, the neck portion 23 has an upper surface 44 that is continuous to the point P1 at the upper end of the first inner surface 41, and further has an outer wall surface 45 that is continuous from the outermost point P4 of the upper surface 44 in the radial direction. The upper surface 44 and the outer wall surface 45 both face the external space of the container 102. The upper surface 44 is parallel to the horizontal direction, and the outer wall surface 45 faces the external space on the side of the container 102. As shown in FIG. 7, the upper part of the outer wall surface 45 according to this embodiment has a rounded shape that is convex outward in the radial direction when viewed from the side. Note that the upper surface 44 may be inclined with respect to the horizontal plane. Further, the upper surface 44 can be omitted.
以上の構成より、揮散体3の外表面に付着した薬液は、当該外表面に沿って滴り落ち、しばしば揮散体3と首部23との接点、本実施形態では、揮散体3と第2内面42との接点となる点P2付近に溜まることがある。しかしながら、この薬液が容器102の外壁面45に達することはない。すなわち、第1内面41が上下方向に延びているため、これが空間S3の外壁となって、空間S3が「薬液のプール」となる。そのため、薬液が、第1内面41及び上面44を超えて外壁面45に達することがない。その結果、容器102の外壁面45に沿って薬液が滴り落ち、薬液で外壁面45が汚れてしまうことが防止される。ひいては、容器102の外壁面45に触れる人の手や壁や家財等が薬液で汚れることもない。また、本実施形態では、空間S3の底面を構成する第3内面43が径方向内側に向かう程、下に向かうように傾斜しているため、空間S3内に漏れ出た薬液は重力により、第3内面43に沿って容器102の内部空間S2内に戻される。なお、このことは、同じく径方向内側に向かう程、下に向かうように傾斜している第1内面41についても同様である。そのため、益々、薬液が外壁面45を汚す虞が低減される。 With the above configuration, the chemical liquid adhering to the outer surface of the volatilization body 3 drips down along the outer surface, often at the contact point between the volatilization body 3 and the neck 23, or in this embodiment, at the point of contact between the volatilization body 3 and the second inner surface 42. may accumulate near point P2, which is the point of contact with. However, this chemical solution never reaches the outer wall surface 45 of the container 102. That is, since the first inner surface 41 extends in the vertical direction, it becomes an outer wall of the space S3, and the space S3 becomes a "pool of chemical solution." Therefore, the chemical solution does not reach the outer wall surface 45 beyond the first inner surface 41 and the upper surface 44. As a result, the chemical solution is prevented from dripping along the outer wall surface 45 of the container 102 and the outer wall surface 45 is prevented from becoming contaminated with the chemical solution. Furthermore, the hands of the person who touches the outer wall surface 45 of the container 102, the wall, household goods, etc., will not be soiled with the chemical solution. Furthermore, in the present embodiment, the third inner surface 43 constituting the bottom surface of the space S3 is inclined downwardly toward the inside in the radial direction, so that the chemical solution leaking into the space S3 is caused by gravity. 3 is returned into the internal space S2 of the container 102 along the inner surface 43. Note that this also applies to the first inner surface 41, which is inclined downwardly toward the inside in the radial direction. Therefore, the risk of the chemical liquid staining the outer wall surface 45 is further reduced.
以上のとおり、薬液が外壁面45を汚さないようにする観点からは、第1内面41の上端の点P1と第2内面42の上端の点P2との間の上下方向の長さw1は、0.5mm≦w1であることが好ましく、1.0mm≦w1であることがより好ましく、2.0mm≦w1であることがさらに好ましい。また、w1≦30mmであることが好ましく、w1≦20mmであることがより好ましく、w1≦10mmであることがさらに好ましい。また、同様の観点から、第1内面41の上端の点P1と第2内面42の上端の点P2との間の水平方向の長さw2は、1.0mm≦w2であることが好ましく、2.0mm≦w2であることがより好ましく、3.0mm≦w2であることがさらに好ましい。また、w2≦45mmであることが好ましく、w2≦30mmであることがより好ましく、w2≦15mmであることがさらに好ましい。 As described above, from the viewpoint of preventing the chemical solution from staining the outer wall surface 45, the length w1 in the vertical direction between the point P1 at the upper end of the first inner surface 41 and the point P2 at the upper end of the second inner surface 42 is It is preferable that 0.5 mm≦w1, more preferably 1.0 mm≦w1, and even more preferably 2.0 mm≦w1. Moreover, it is preferable that w1≦30 mm, more preferably that w1≦20 mm, and even more preferably that w1≦10 mm. Further, from the same viewpoint, the horizontal length w2 between the upper end point P1 of the first inner surface 41 and the upper end point P2 of the second inner surface 42 is preferably 1.0 mm≦w2; It is more preferable that .0 mm≦w2, and even more preferable that 3.0 mm≦w2. Moreover, it is preferable that w2≦45 mm, more preferably that w2≦30 mm, and even more preferably that w2≦15 mm.
<3.変形例>
以上、本発明の一実施形態について説明したが、本発明は上記実施形態に限定されるものではなく、その趣旨を逸脱しない限りにおいて、種々の変更が可能である。例えば、以下の変更が可能である。また、以下の変形例の要旨は適宜組み合わせることができる。
<3. Modified example>
Although one embodiment of the present invention has been described above, the present invention is not limited to the above embodiment, and various changes can be made without departing from the spirit thereof. For example, the following changes are possible. Furthermore, the gist of the following modifications can be combined as appropriate.
<3-1>
図8に示すように、外壁面45は、側面視において点P4から下方へ略真っ直ぐに延びていてもよい。
<3-1>
As shown in FIG. 8, the outer wall surface 45 may extend substantially straight downward from point P4 in side view.
<3-2>
第2実施形態では、首部23の第1内面41は、上に向かう程、径方向外側に向かうように傾斜していたが、上下方向に平行に延びていてもよいし、図9に示すように上に向かう程、径方向内側に向かうように傾斜していてもよい。第3内面43についても、同様であり、水平方向に平行に延びていてもよいし、図9に示すように上に向かう程、径方向内側に向かうように傾斜していてもよい。また、第1及び第2実施形態において、第2内面42が上下方向に延びている必要はなく、上に向かう程、径方向外側又は内側に向かうように傾斜していてもよい。
<3-2>
In the second embodiment, the first inner surface 41 of the neck portion 23 is inclined radially outward toward the top, but it may also extend parallel to the vertical direction, or as shown in FIG. It may be inclined so that it goes radially inward as it goes upward. The same applies to the third inner surface 43, which may extend parallel to the horizontal direction, or may be inclined upwardly and radially inwardly as shown in FIG. Further, in the first and second embodiments, the second inner surface 42 does not need to extend in the vertical direction, and may be inclined so as to be radially outward or inward as it goes upward.
<3-3>
図10に示すように、第2内面42の上部及び第1内面41が丸みを帯びていてもよい。すなわち、第2内面42の上部及び第1内面41が、側面視において湾曲していてもよい。
<3-3>
As shown in FIG. 10, the upper part of the second inner surface 42 and the first inner surface 41 may be rounded. That is, the upper part of the second inner surface 42 and the first inner surface 41 may be curved in side view.
<3-4>
上記実施形態の容器2,102は、その全体が一体的に構成されていた。しかしながら、図11に示すように、第1内面41を構成する部分と、第2内面42を構成する部分とが別体であってもよい。例えば、第1内面41を含む本体部41aをガラスで構成し、本体部41aに第2内面42を含む部材42aを取り付けることができる。このとき、第2内面42を含む部材42aは、第1内面41を含む本体部41aに取り付けやすいよう、ゴムや樹脂等の弾性材料から構成し、嵌め込み式とすることができる。
<3-4>
The container 2,102 of the above embodiment was entirely constructed in one piece. However, as shown in FIG. 11, the portion constituting the first inner surface 41 and the portion constituting the second inner surface 42 may be separate bodies. For example, the main body portion 41a including the first inner surface 41 may be made of glass, and the member 42a including the second inner surface 42 may be attached to the main body portion 41a. At this time, the member 42a including the second inner surface 42 may be made of an elastic material such as rubber or resin and may be of an insert type so that it can be easily attached to the main body portion 41a including the first inner surface 41.
1 薬液揮散器
2,102 容器
3 揮散体
3a 下端部
3b 上端部
32 首部(周縁部)
41 第1内面
42 第2内面
D1 段差
S1 開口
1 Chemical solution volatilizer 2, 102 Container 3 Volatile body 3a Lower end 3b Upper end 32 Neck (periphery)
41 First inner surface 42 Second inner surface D1 Step S1 Opening
Claims (6)
前記容器内に収容される薬液と、
前記薬液を前記容器内から吸い上げ、外部空間に揮散させるべく、前記容器外へ一部が露出するように前記開口を介して前記容器内に挿入される棒状の揮散体と
を備え、
前記容器は、前記開口を囲んで前記開口を画定する周縁部を含み、
前記周縁部は、前記開口に面する第1内面と、前記開口に面し、前記第1内面よりも前記開口の径方向内側に位置するとともに、前記第1内面よりも下方に位置する第2内面とを有し、
前記第1内面と前記第2内面とは、段差を形成しており、
前記揮散体は、全体が前記容器に対して傾くように前記容器内に挿入可能であり、
前記揮散体のうちの前記容器外に露出している部分の長さは、前記揮散体のうちの前記容器内に挿入されている部分の長さよりも長く、
前記容器の前記開口が外部空間に面しており、
前記容器内に挿入された前記揮散体は、前記第1内面と距離を保ちつつ、前記第2内面と接触する、
薬液揮散器。 a container having an opening at the top;
A medical solution contained in the container;
a rod-shaped volatilization body inserted into the container through the opening so that a portion thereof is exposed outside the container in order to suck up the chemical solution from inside the container and volatilize it into an external space;
the container includes a periphery surrounding and defining the opening;
The peripheral edge portion includes a first inner surface facing the opening, and a second inner surface facing the opening, located radially inward of the opening than the first inner surface, and located below the first inner surface. has an inner surface,
The first inner surface and the second inner surface form a step,
The volatile body can be inserted into the container so that the entire body is inclined with respect to the container,
The length of the part of the volatile body exposed outside the container is longer than the length of the part of the volatile body inserted into the container,
the opening of the container faces an external space;
The volatilization body inserted into the container contacts the second inner surface while maintaining a distance from the first inner surface.
Chemical vaporizer.
請求項1に記載の薬液揮散器。 The peripheral edge portion is between the first inner surface and the second inner surface and has a third inner surface facing the opening.
The chemical solution volatilizer according to claim 1.
請求項2に記載の薬液揮散器。 The first inner surface and the third inner surface form an inclined surface that is inclined toward the outer side in the radial direction of the opening as it goes upward.
The chemical solution volatilizer according to claim 2.
請求項1から3のいずれかに記載の薬液揮散器。 The angle formed between the vertical direction and the straight line connecting the upper end of the first inner surface and the upper end of the second inner surface, which are located at the same position in the circumferential direction of the opening, is such that the volatilized material is the most in the container with respect to the vertical direction. The chemical volatilizer according to any one of claims 1 to 3, wherein the axial direction of the volatilization body in an inclined state is larger than the angle made with the vertical direction.
請求項1から3のいずれかに記載の薬液揮散器。 The angle between the axial direction of the volatilization body and the horizontal plane when the volatilization body is most inclined with respect to the vertical direction in the container is the angle between the upper end of the first inner surface at the same position in the circumferential direction of the opening and the The chemical solution volatilizer according to any one of claims 1 to 3, which is larger than the angle formed by the horizontal plane and a straight line connecting the upper end of the second inner surface.
請求項1から5のいずれかに記載の薬液揮散器。
The chemical solution volatilizer according to any one of claims 1 to 5, wherein a portion constituting the first inner surface and a portion constituting the second inner surface are separate bodies.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016256266A JP7359526B2 (en) | 2016-12-28 | 2016-12-28 | Chemical liquid volatilizer |
| JP2021066692A JP7162095B2 (en) | 2016-12-28 | 2021-04-09 | Chemical volatilizer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016256266A JP7359526B2 (en) | 2016-12-28 | 2016-12-28 | Chemical liquid volatilizer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021066692A Division JP7162095B2 (en) | 2016-12-28 | 2021-04-09 | Chemical volatilizer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018108827A JP2018108827A (en) | 2018-07-12 |
| JP7359526B2 true JP7359526B2 (en) | 2023-10-11 |
Family
ID=62844181
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016256266A Active JP7359526B2 (en) | 2016-12-28 | 2016-12-28 | Chemical liquid volatilizer |
| JP2021066692A Active JP7162095B2 (en) | 2016-12-28 | 2021-04-09 | Chemical volatilizer |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021066692A Active JP7162095B2 (en) | 2016-12-28 | 2021-04-09 | Chemical volatilizer |
Country Status (1)
| Country | Link |
|---|---|
| JP (2) | JP7359526B2 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111095120B (en) | 2017-09-11 | 2022-02-25 | 佳能株式会社 | Developer bearing member, process cartridge, and electrophotographic apparatus |
| JP2020116111A (en) * | 2019-01-23 | 2020-08-06 | 株式会社カーメイト | Inner plug for volatilizer and volatilizer |
| JP7720131B2 (en) * | 2019-03-29 | 2025-08-07 | 小林製薬株式会社 | Chemical vaporizer |
| JP7240225B2 (en) * | 2019-03-29 | 2023-03-15 | 小林製薬株式会社 | Chemical volatilizer |
| JP7423276B2 (en) * | 2019-11-27 | 2024-01-29 | エステー株式会社 | Volatilization device |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4722411B2 (en) * | 2004-05-17 | 2011-07-13 | アース製薬株式会社 | Volatilization equipment |
| JP5432090B2 (en) * | 2010-08-27 | 2014-03-05 | エステー株式会社 | Volatilization equipment |
| JP3178496U (en) * | 2012-06-19 | 2012-09-20 | Hanaemi株式会社 | Three-way fragrance set |
| JP6090667B2 (en) * | 2013-05-30 | 2017-03-08 | 株式会社吉野工業所 | Inner plug with guide mechanism |
| JP2015100649A (en) * | 2013-11-28 | 2015-06-04 | エステー株式会社 | Inside plug and vaporization device |
| JP6280825B2 (en) * | 2014-03-26 | 2018-02-14 | 小林製薬株式会社 | container |
| JP6670044B2 (en) * | 2015-01-06 | 2020-03-18 | 小林製薬株式会社 | Drug vaporizer |
-
2016
- 2016-12-28 JP JP2016256266A patent/JP7359526B2/en active Active
-
2021
- 2021-04-09 JP JP2021066692A patent/JP7162095B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP7162095B2 (en) | 2022-10-27 |
| JP2018108827A (en) | 2018-07-12 |
| JP2021104862A (en) | 2021-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7162095B2 (en) | Chemical volatilizer | |
| JP5319416B2 (en) | Volatilization equipment | |
| JP6170759B2 (en) | Chemical volatilizer | |
| JP6721381B2 (en) | Chemical solution volatilizer | |
| WO2012026310A1 (en) | Volatilization device | |
| KR20130083300A (en) | Supporting device for volatilization perfume stick and perfume bottle having herewith | |
| JP2019130259A (en) | Aroma tool evapotranspiration stick support method | |
| JP7356249B2 (en) | Chemical liquid volatilizer | |
| JP7240225B2 (en) | Chemical volatilizer | |
| JP7720131B2 (en) | Chemical vaporizer | |
| JP6960008B2 (en) | Chemical volatilizer | |
| JP7661130B2 (en) | Volatilization device and volatilization device kit | |
| JP2020164229A (en) | Chemical vaporizer | |
| JP7686363B2 (en) | Drug volatilizer | |
| JP7729718B2 (en) | volatilization device | |
| JP6002558B2 (en) | Chemical volatilization device | |
| JP7516224B2 (en) | Chemical container and volatilizer | |
| JP2017095122A (en) | Chemical volatilizer | |
| JP5806906B2 (en) | Volatilizer | |
| JP2023071266A (en) | Liquid container and medicine volatilizer | |
| JP7362295B2 (en) | Drug containers and drug volatilizers | |
| JP5827855B2 (en) | Volatilizer | |
| JP6752504B2 (en) | Volatilization container | |
| JP2022090700A (en) | Drug volatilizer | |
| JP2019208567A (en) | Volatile body and agent volatilizer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20191113 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210302 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210409 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210907 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20211028 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20220322 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220620 |
|
| C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20220620 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20220701 |
|
| C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20220705 |
|
| A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20220812 |
|
| C211 | Notice of termination of reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C211 Effective date: 20220816 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230928 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7359526 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |